Clinically, ACC samples with high METTL1 expression exhibit reduced CD8+ T cell infiltration and increased macrophage infiltration; METTL1 knockdown significantly inhibits xenograft tumor growth in mice (60). Here, METTL1 is linked to neoplasm.